Latest Breaking News On - Adjusted diluted weighted average shares - Page 1 : comparemela.com

ENDO REPORTS SECOND-QUARTER 2023 FINANCIAL RESULTS

/PRNewswire/ Endo International plc (OTC: ENDPQ) today reported financial results for the second-quarter ended June 30, 2023. SECOND-QUARTER FINANCIAL.

Mallinckrodt amitizaGeneric pharmaceuticalsBranded pharmaceuticalsEndo internationalPfizer incCompany incomeEndo investor relations departmentCompany chapterExchange commissionTakeda pharmaceutical united statesa incPaladin labs incPrnewswire endo internationalTakeda pharmaceuticals united states incInternational pharmaceuticalsNovavax incMonths ended june

Endo International plc: ENDO REPORTS SECOND-QUARTER 2023 FINANCIAL RESULTS

Endo International plc: ENDO REPORTS SECOND-QUARTER 2023 FINANCIAL RESULTS
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Mallinckrodt amitizaBranded pharmaceuticalsExchange commissionGeneric pharmaceuticalsCompany chapterPaladin labs incTakeda pharmaceutical united statesa incCompany incomeNovavax incPfizer incInternational pharmaceuticalsTakeda pharmaceuticals united states incPrnewswire endo internationalEndo investor relations departmentMonths ended juneDiluted net income

ENDO REPORTS FIRST-QUARTER 2023 FINANCIAL RESULTS

DUBLIN, May 8, 2023 /PRNewswire/ Endo International plc today reported financial results for the first-quarter ended March 31, 2023. . | May 8, 2023

Prnewswire endo internationalCompany lossInternational pharmaceuticalsTakeda pharmaceutical united statesa incPfizer incBranded pharmaceuticalsCompany chapterPaladin labs incEndo internationalExchange commissionEndo investor relations departmentGeneric pharmaceuticalsTakeda pharmaceuticals united states incMonths ended marchDiluted net lossContinuing operations

ENDO REPORTS FOURTH-QUARTER 2022 FINANCIAL RESULTS

/PRNewswire/ Endo International plc (OTC: ENDPQ) today reported financial results for the fourth-quarter ended December 31, 2022. FOURTH-QUARTER FINANCIAL.

Prnewswire endo internationalBranded pharmaceuticalsPaladin labs incGeneric pharmaceuticalsEndo investor relations departmentExchange commissionInternational pharmaceuticalsPfizer incEndo internationalCompany lossCompany chapterMonths ended decemberEnded decemberDiluted net lossContinuing operationsDiluted weighted average shares

Endo International plc: ENDO REPORTS THIRD-QUARTER 2022 FINANCIAL RESULTS

DUBLIN, Nov. 9, 2022 /PRNewswire/ Endo International plc (OTC: ENDPQ) today reported financial results for the third-quarter ended September 30, 2022. THIRD-QUARTER FINANCIAL PERFORMANCE (in

Prnewswire endo internationalBranded pharmaceuticalsPaladin labs incGeneric pharmaceuticalsEndo investor relations departmentExchange commissionInternational pharmaceuticalsPfizer incCompany lossCompany chapterMonths ended septemberDiluted net lossDiluted net incomeContinuing operationsAdjusted diluted weighted average sharesAdjusted income